SCS-C006140

5,9-dihydroxy-2,4,6,8,10-pentamethyldodeca-2,6,10-trienal

Pathway: Polyketides Superclass: Linear polyketides Class: Open-chain polyketides

Chemical Structure

Structure of 5,9-dihydroxy-2,4,6,8,10-pentamethyldodeca-2,6,10-trienal
Loading 3D structure...
3D conformers are computationally generated from SMILES by RDKit for visualization and download; they are not experimental crystal or NMR structures.
Download: SDF SMILES

Source Information

Aspergillus ochraceopetaliformis (NA)
Offshore Hainan Island  · 18.216° N, 109.495° E
DOI: 10.3390/md20050295  · Marine Drugs

Drug-likeness (Lipinski Ro5)

Molecular Weight
280.4 Da
Threshold ≤ 500
ALogP
3.04
Threshold ≤ 5
H-Bond Donors
2
Threshold ≤ 5
H-Bond Acceptors
3
Threshold ≤ 10
Passes Lipinski Rule of Five — drug-like candidate

Chemical Properties

Molecular Formula:
C17H28O3
Molecular Weight:
280.4080 Da
SMILES:
C/C=C(\C)[C@@H](O)[C@@H](C)/C=C(\C)[C@@H](O)[C@@H](C)/C=C(\C)C=O
InChIKey:
VOGAFVFYRPIPRX-INZDULQCSA-N
InChI:
InChI=1S/C17H28O3/c1-7-12(3)16(19)14(5)9-15(6)17(20)13(4)8-11(2)10-18/h7-10,13-14,16-17,19-20H,1-6H3/b11-8+,12-7+,15-9+/t13-,14-,16+,17-/m0/s1
Calculated Properties
ALogP:
3.038 lipophilicity
TPSA:
57.53 Ų polar surface area
H-Bond Donors:
2
H-Bond Acceptors:
3
Rotatable Bonds:
7
Ring Count:
0 (0 aromatic)
Chiral Centers:
4
Fsp³:
0.5882 fraction sp³ carbon

Database Information

Compound ID:
SCS-C006140
NPClassifier Pathway:
Polyketides
NPClassifier Superclass:
Linear polyketides
NPClassifier Class:
Open-chain polyketides
Glycoside:
No
NPClassifier Status:
Classified
External Links:

Biological Activity Data

Activity values are displayed only when a quantitative or clearly reported result is available. Tested organisms, cell lines and molecular targets are shown under Target / model.
Activity Assay Target / model Result Reference
Anti-inflammatory inhibition nitric oxide (NO) production — Structured numeric value is not available in this record; see the primary reference. 10.3390/md20050295 Marine Drugs
Anti-inflammatory inhibition IL-6; TNF-α compounds 2, 5, and 6 inhibited the levels of IL-6, TNF-α, and MCP-1 upregulated by LPS administration in culture medium. 10.3390/md20050295 Marine Drugs
Anti-inflammatory in vivo inhibition pro-inflammatory cytokines (IL-6; TNF-α) — Structured numeric value is not available in this record; see the primary reference. 10.3390/md20050295 Marine Drugs
Structure enlarged